Fosamax Class Action Ruling Expected to Result in Many More Dead Jaw Syndrome Lawsuits Against Merck
People taking Fosamax for osteoporosis are now facing concerns that they risk developing Osteonecrosis of the Jaw (ONJ). For those who have developed ONJ, their legal recourse is to file individual lawsuits against Fosamax manufacturer Merck. If successful, the settlements from these lawsuits will pay for on-going medical treatments and compensation for pain and suffering associated with the condition. A recent federal court ruling has refused class action status for Fosamax complaints, thus pushing many of these cases toward individual lawsuits.